New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 27, 2014
09:36 EDTWMT, MRK, C, TSLA, NFLX, TWTR, GOOG, AAPLActive equity options trading on open
Active equity options trading on open according to Track Data: C AAPL NFLX MA MRK GOOG TSLA WMT TWTR
News For C;AAPL;NFLX;MRK;GOOG;TSLA;WMT;TWTR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | all recent news | >>
November 10, 2014
09:35 EDTAAPLActive equity options trading
Subscribe for More Information
09:20 EDTMRKOn The Fly: Pre-market Movers
Subscribe for More Information
09:00 EDTWMTWal-Mart weekly volatility increases into Q3 and holiday outlook
Subscribe for More Information
08:48 EDTMRKGilead rises after Merck presents data on HCV combo
Subscribe for More Information
08:23 EDTWMTWal-Mart expectations appear muted heading into earnings, says RW Baird
Subscribe for More Information
07:34 EDTAAPLApple Pay seen making up 1% of Whole Foods transactions since launch, Dudas says
Subscribe for More Information
07:23 EDTNFLXRBC Capital to hold a conference
Subscribe for More Information
07:20 EDTMRKGilead overhang from Merck HCV combo removed, says Wells Fargo
Subscribe for More Information
07:12 EDTTWTRCA Technologies to hold a conference
CA World 2014 is being held in Las Vegas on November 9-12.
07:11 EDTGOOGOpen Mobile Media to hold a summit
Subscribe for More Information
06:46 EDTCRegulators set new capital buffer rule for banks, Reuters reports
Global banks should have buffers of bonds or equity worth 16%-20% of their risk-weighted assets, beginning in January 2019, The Financial Stability Board decided, according to Reuters. The board said the buffer would prevent the need for government bailouts, the news service explained. Publicly traded global banks include Bank of America (BAC), Citigroup (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) Wells Fargo (WFC), Banco Santander (SAN), Barclays (BCS), Credit Suisse (CS), Deutsche Bank (DB), HSBC (HSBC), ING Groep (ING), Lloyds Banking (LYG), RBS (RBS) and UBS (UBS). Reference Link
06:37 EDTCSumitomo Mitsui in lead for Citigroup's Japan retail operations, WSJ reports
Subscribe for More Information
06:27 EDTAAPLGT Advanced accuses Apple of 'bait-and-switch' in unsealed documents, WSJ says
Subscribe for More Information
06:18 EDTCUBS to settle misconduct allegations at precious metals trading unit, FT reports
Subscribe for More Information
06:04 EDTGOOGGoogle's same-day delivery head leaves for Uber, Re/code reports
The head of Google Express' same-day delivery service, Tom Fallows, has left the company to join Uber, Re/code reported on Friday, citing sources. Reference Link
06:00 EDTAAPLApple implied volatility of 19 at lower end of index mean range
Subscribe for More Information
05:58 EDTNFLXStocks with implied volatility below IV index mean; CHK NFLX
Subscribe for More Information
November 9, 2014
18:58 EDTMRKMerck presents interim data from C-SWIFT study
Merck announced the presentation of interim data from the C-SWIFT study exploring the potential of a candidate triple-therapy regimen consisting of the fixed-dose combination of grazoprevir/elbasvir , the company’s investigational NS3/4A protease inhibitor and NS5A inhibitor, in combination with sofosbuvir, a nucleotide inhibitor for the treatment of chronic hepatitis C virus, HCV, infection. Preliminary findings in treatment-naïve HCV genotype 1- infected non-cirrhotic patients, following six and four weeks of treatment, and patients with cirrhotic disease, following eight and six weeks of treatment, will be presented by Dr. Eric Lawitz, vice president, scientific and research development, The Texas Liver Institute, San Antonio, TX and C-SWIFT lead investigator. This poster presentation is part of a late-breaking abstract session at the 65th American Association for the Study of Liver Diseases, AASLD, Annual Meeting, also known as The Liver Meeting. “These interim data provide a compelling proof-of-concept for the potential of an eight- or six-week triple therapy course in treatment-naive patients with genotype 1 disease, including cirrhotic patients,” said Dr. Lawitz. “These findings will inform the design of larger studies aimed at understanding the potential of short-duration triple therapy across multiple patient types.”
18:41 EDTWMTWal-Mart to focus on food safety in China, Reuters says
Subscribe for More Information
16:55 EDTWMTWal-Mart China sales impacted by country's austerity program, WSJ says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use